Catalyst Wire Dossier Catalyst Wire Dossier

ALPN-101

Acazicolcept · Alpine Immune Sciences Inc, A Subsidiary of Vertex
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALPN-101, covering 2025-08-15 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus [Phase 2]

See pricing